Chemoinformaics analysis of 1-(4-HYDROXY-3-METHOXYPHENYL)-3-OXODECANE-5-SULFONIC ACID
| Molecular Weight | 358.456 | nRot | 11 |
| Heavy Atom Molecular Weight | 332.248 | nRig | 1 |
| Exact Molecular Weight | 358.145 | nRing | 1 |
| Solubility: LogS | -0.455 | nHRing | 0 |
| Solubility: LogP | 0.888 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 1 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 53.4386 |
| nHD | 2 | BPOL | 35.3434 |
| QED | 0.511 |
| Synth | 1.813 |
| Natural Product Likeliness | -0.249 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.002 |
| CACO-2 | -4.293 |
| MDCK | 0.000116461 |
| BBB | 0.995 |
| PPB | 0.238786 |
| VDSS | 1.056 |
| FU | 0.802294 |
| CYP1A2-inh | 0.764 |
| CYP1A2-sub | 0.535 |
| CYP2c19-inh | 0.194 |
| CYP2c19-sub | 0.818 |
| CYP2c9-inh | 0.024 |
| CYP2c9-sub | 0.11 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.363 |
| CYP3a4-inh | 0.027 |
| CYP3a4-sub | 0.326 |
| CL | 11.984 |
| T12 | 0.792 |
| hERG | 0.013 |
| Ames | 0.021 |
| ROA | 0.013 |
| SkinSen | 0.693 |
| Carcinogencity | 0.036 |
| EI | 0.965 |
| Respiratory | 0.162 |
| NR-Aromatase | 0.003 |
| Antiviral | Yes |
| Prediction | 0.603822 |